Bialer M., Johannsenn S.I., Kupferberg H.J., Levy R.H., Loiseau P., Perucca E. Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV). Epilepsy Res. 34:1999;1-41.
Cramer J.A., Fisher R., Ben-Menachem E., French J., Mattson R.H. New antiepileptic drugs: comparison of key clinical trials. Epilepsia. 40(5):1999;590-600.
Dreier J.P., Heinemann U. Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid. Neurosci. Lett. 119:1990;68-70.
Eckstein-Ludwig U., Fei J., Schwartz W. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs. Br. J. Pharmacol. 128:1999;92-102.
Frerking M., Borges S., Wilson M. Variation in GABA mini amplitude is the consequence of variation in transmitter concentration. Neuron. 15:1995;885-895.
Golan H., Talpalar A.E., Schleifstein-Attias D., Grossmann Y. GABA metabolism controls inhibition efficacy in the mammalian CNS. Neurosci. Lett. 217:1996;25-28.
Gram L., Larsson O.M., Johnsen A.H., Schousboe A. Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons. Epilepsy Res. 2:1988;87-95.
Jackson M.F., Dennis T., Esplin B., Capek R. Acute effects of GVG on hippocampal GABAergic inhibition in vitro. Brain Res. 65:1994;85-91.
Jolkkonen J., Mazurkiewicz M., Lahtinen H., Riekkinen P. Acute effects of γ-vinyl-GABA on the GABAergic system in rats as studied by microdialysis. Eur. J. Pharmacol. 229:1992;269-272.
Kocsis J.D., Mattson R.H. GABA levels in the brain: a target for new antiepileptic drugs. Neuroscience. 6:1996;326-334.
Leach J.P., Sills G.J., Majid A., Butler E., Carswell A., Thompson G.G., Brodie M.J. Effects of tiagabine and vigabatrin on GABA uptake into primary cultures of rat cortical astrocytes. Seizure. 5(3):1996;229-234.
Löscher W., Jäckel R., Müller F. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model. Eur. J. Pharmacol. 163:1989;1-14.
Lücke A., Mußhoff U., Köhling R., Osterfeld M., Mayer T., Wolf P., Schütte W., Speckmann E.-J. Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy. Br. J. Pharmacol. 124:1998;370-376.
Nusser Z., Cull-Candy S., Farrant M. Differences in synaptic GABAA receptor number underlie variations in GABA mini amplitude. Neuron. 19:1997;697-709.
Petroff O.A., Rothman D.L. Measuring human brain GABA in vivo. Mol. Neurobiol. 16:1998;97-121.
Pfeiffer M., Draguhn A., Meierkord H., Heinemann U. Effects of γ-aminobutyric (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro. Br. J. Pharmacol. 119:1996;569-577.
Rundfeldt C., Löscher W. Development of tolerance to the anticonvulsant effect of vigabatrin in amygdala-kindled rats. Eur. J. Pharmacol. 213:1992;351-366.
Sanchez-Alcaraz A., Quintana B., Rodriguez I., López E. Plasma concentrations of vigabatrin in epileptic patients. J. Clin. Pharm. Ther. 21:1996;393-398.
Sander J.W.A.S., Duncan J.S. Vigabatrin. Shoervon S., Dreifuss F., Fish D., Thomas D. The Treatment of Epilepsy. 1996;491-499 Blackwell Science, Oxford.
Schousboe A., Larsson O.M., Wood J.D., Kroogsgaard-Larsen P. Transport and metabolism of γ-aminobutyric acid in neurons and glia: implications for epilepsy. Epilepsia. 24:1983;531-538.
Suzuki Y., Kuriyama K. Effect of γ-vinyl γ-aminobutyric acid on the γ-aminobutyric acid receptor-coupled chloride channel in vesicles from the brain of the rat. Neuropharmacology. 30(5):1991;423-427.
Whittington M.A., Traub R.D., Jefferys J.G.R. Erosion of inhibition contributes to the progression of low magnesium bursts in rat hippocampal slices. J. Physiol. London. 468:1995;723-734.
Ylinen A., Sivinius J., Pitkänen T., Halonen J., Partanen E., Mervaala E., Mumford J.P., Riekkinen P.J. γ-Vinyl-GABA (vigabatrin) in epilepsy: clinical, neurochemical and neurophysiologic monitoring in epileptic patients. Epilepsia. 33:1992;917-922.
Yonekawa W.D., Kapetanovic I.M., Kupferberg H.J. The effects of anticonvulsant agents on 4-aminopyridine induced epileptiform activity in rat hippocampus in vitro. Epilepsy Res. 20:1995;137-150.
Zhang C.L., Dreier J.P., Heinemann U. Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res. 20:1995;105-111.
